Author: user

[ad_1] Image source: Getty Images FTSE 100 home improvement retailer Kingfisher (LSE: KGF) has risen 23% from 23 September. I am not surprised, given its excellent H1 2025 results released on that day. The owner of the UK’s B&Q and Screwfix, France’s Castorama, and Brico Depot across Europe, posted a £368m pre-tax profit. This was up 10.2% year on year, on a 1.3% like-for-like (LFL) rise in sales to £6.811bn. LFL sales measure a retail business’s growth from its existing stores and space, excluding new store openings or closures. Adjusted earnings per share jumped 16.5% over the period to 15.3p,…

Read More

[ad_1] Image source: Getty Images One of the best-performing FTSE 100 stocks from last month was BAE Systems (LSE:BA.). Thanks to factors including major contract wins and rising geopolitical risks, the BAE share price surged 17% during the month, pushing the stock to fresh 52-week highs. Here’s what happened and where things could go from here. Reasons for the spike One catalyst appears to be a £10bn warship contract with Norway selecting the UK for supply of Type 26 frigates. That deal was highlighted as the biggest ever warship export deal by value. Although the exact financial benefit for BAE…

Read More

[ad_1] Image source: Getty Images The past year has been a catastrophic period for Greggs‘ (LSE:GRG) share price. Down more than 40%, the baker’s slumped as enduring pressure on consumers’ wallets — and more recently warm weather — have hit sales of its sausage rolls, pasties and sweet treats. Greggs’ fresh update today (1 October) revealed more of the same generally speaking, with like-for-like sales growing just 1.5% in the 13 weeks to 27 September. Turnover was up 2.2% in the year to date, revealing that, for now at least, the breakneck sales growth it previously enjoyed remains elusive. Yet…

Read More

[ad_1] Image source: Getty Images On 24 September, the JD Sports Fashion (LSE:JD.) share price closed 0.7% lower, at 87.9p, after the group released its results for the 26 weeks ended 2 August. Compared to the same period in 2024, the sports and leisure retailer reported a 20% increase in sales and a 9.5% rise in pre-tax profit. But look closer… However, this includes the full six-month impact of two acquisitions. On a like-for-like basis, sales were down 2.5%. The lukewarm response of investors appears to reflect concerns about this lack of top-line growth. Although the group’s share price has…

Read More

[ad_1] Please Register or Sign in to view this content. Quantum Commodity Intelligence is a premium paid subscription service for professionals in the oil, biofuels, carbon, ammonia and hydrogen markets. Quantum Carbon service subscribers have access to: Daily price assessments Market news and price commentary Fundamental trade data Quantum Carbon Daily – market report sent to your email Get in touch with us for subscription information on all Quantum platforms, or help with the service. [ad_2] Source link

Read More

[ad_1] For the first time in UN climate negotiations, carbon dioxide removal (CDR) will have its own dedicated space. The COP30 Presidency has confirmed the creation of the CDR30 Pavilion, a landmark pavilion inside the UNFCCC Blue Zone in Belém, Brazil, placing carbon removals at the heart of global climate diplomacy.Coordinated by the Negative Emissions Platform (NEP) and supported through CDR30: The Global CDR Initiative at COP30, the pavilion is backed by more than 90 organizations spanning companies, NGOs, research bodies, investors, and philanthropies.The IPCC has made clear that achieving net-zero is impossible without large-scale carbon removals. Scientific assessments show…

Read More

[ad_1] Nvidia’s (NASDAQ: NVDA) share price continues to move higher. This year, it’s climbed from $134 to $187 – a gain of about 40%. Wondering what level the chip stock could get to in the medium term? Here’s my share price forecast for 2026. Huge demand for its GPUs Before crunching the numbers, it’s worth looking at the backdrop here. Because it’s quite remarkable. Nvidia designs high-powered chips (GPUs) for artificial intelligence (AI). And right now, tech companies like OpenAI (ChatGPT), Meta Platforms, Alphabet, and Oracle can’t get enough of them. Recently, I was listening to an interview with OpenAI…

Read More

[ad_1] Image source: Getty Images BAE Systems (LSE: BA) share price is trading around an all-time high at £20.59. This marks a 243% increase from its opening price on 24 February 2022 when Russia invaded Ukraine. And over this year alone it has risen 80% from its 6 January traded low of £11.44. However, experience has taught me that a share’s price and value are different things. I spent several years as a senior investment bank trader and three decades so far as a private investor. Price is just the figure that markets are willing to pay for a stock…

Read More

[ad_1] Image source: Getty Images There’s never a dull moment with Tesla (NASDAQ:TSLA) shares. And while that isn’t always a good thing, there’s no arguing with the fact the stock was a terrific asset for investors in September. The share price climbed 34% last month and the reasons are interesting to say the least. But the big issue for investors is where the company goes from here. Buying The straightforward reason any stock goes up is that demand from buyers is outstripping supply from sellers. But there’s been an interesting dynamic with Tesla in the last few weeks. When company…

Read More

[ad_1] WESTLAKE VILLAGE, Calif., September 29, 2025–(BUSINESS WIRE)–Turn Therapeutics (“Turn” or the “Company”), a clinical-stage biotechnology company developing dermatology, wound care, and anti-infective therapies, today announced that it expects its common stock will begin trading on the Nasdaq Global Market under the ticker symbol “TTRX” on October 8, 2025. Copies of the prospectus, when available, may be obtained from Turn Therapeutics, 250 N. Westlake Blvd., Westlake Village, CA 91362. About Turn Therapeutics Turn Therapeutics is a biotechnology company developing and commercializing products for dermatology, wound care, and infectious disease. The company has received three FDA clearances for its proprietary wound…

Read More